Results 211 to 220 of about 25,453,690 (257)

Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients

Journal of Medical Genetics, 2015
A. Hexter, Adrian Jones, H. Joe, Laura Heap, Miriam J. Smith, A. Wallace, D. Halliday, A. Parry, Amy Taylor, L. Raymond, A. Shaw, Shazia K Afridi, R. Obholzer, P. Axon, A. King, Jan M. Friedman, David Evans   +16 more
semanticscholar   +1 more source

Long‐term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration

The Laryngoscope, 2016
A. Picry, N. Bonne, Julie Ding, R. Aboukais, J. Lejeune, M. Baroncini, F. Dubrulle, C. Vincent   +7 more
semanticscholar   +1 more source

Neurofibromatosis 2

2000
K, Kitamura, K, Takahashi, H, Kakoi
openaire   +2 more sources

Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients

Cancer Chemotherapy and Pharmacology, 2014
K. Slusarz, V. Merker, A. Muzikansky, Sanjeev A. Francis, S. Plotkin   +4 more
semanticscholar   +1 more source

Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis

International Journal of Molecular Sciences, 2021
Ryota Tamura, Tamura Ryota
exaly  

Neurofibromatosis type 2

Journal of the American Academy of Dermatology, 2001
K S, Caldemeyer, G W, Mirowski
openaire   +2 more sources

The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study

Journal of Neuro-Oncology, 2014
A. Vranceanu, V. Merker, S. Plotkin, E. Park   +3 more
semanticscholar   +1 more source

Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.

Neurosurgery, 2014
Grant W. Mallory, B. Pollock, R. Foote, Matthew L. Carlson, C. Driscoll, M. Link   +5 more
semanticscholar   +1 more source

Neurofibromatosis 2

New England Journal of Medicine, 1988
Robert L. Martuza, Roswell Eldridge
openaire   +1 more source

Neurofibromatosis 2: A novel risk factor for hypertension?

American Journal of Medical Genetics. Part A, 2011
R. Hornigold, J. Golding, R. Ferner, R. Ferner   +3 more
semanticscholar   +1 more source